Doxazosin
- Product NDC
- 68382-783
- 11-digit product format
- 683820783
- Labeler code
- 68382
- Product ID
- 68382-783_92ead971-9de8-4240-b2c7-fc2e9abac7dd
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- Doxazosin
- Dosage form
- TABLET
- Route
- ORAL
- Labeler
- Zydus Pharmaceuticals USA Inc.
- Application
- ANDA208719
- Marketing category
- ANDA
- Marketing start
- 2017-08-31
- Substance
- DOXAZOSIN MESYLATE
- Active strength
- 1 mg/1
- Pharmacologic classes
- Adrenergic alpha-Antagonists [MoA], alpha-Adrenergic Blocker [EPC]
- NDC exclude flag
- No
- Listing certified through
- 2026-12-31
- Current FDA listing
- Yes
Orange Book products#
| Application-product | Trade name | Ingredient | Strength | Dosage form / route | TE codes | RLD / RS | Approval date |
|---|---|---|---|---|---|---|---|
| A208719-001 | DOXAZOSIN MESYLATE | DOXAZOSIN MESYLATE | EQ 1MG BASE | TABLET / ORAL | AB | 2017-07-07 | |
| A208719-002 | DOXAZOSIN MESYLATE | DOXAZOSIN MESYLATE | EQ 2MG BASE | TABLET / ORAL | AB | 2017-07-07 | |
| A208719-003 | DOXAZOSIN MESYLATE | DOXAZOSIN MESYLATE | EQ 4MG BASE | TABLET / ORAL | AB | 2017-07-07 | |
| A208719-004 | DOXAZOSIN MESYLATE | DOXAZOSIN MESYLATE | EQ 8MG BASE | TABLET / ORAL | AB | 2017-07-07 |
Therapeutic equivalence codes#
| Application-product | TE code |
|---|---|
| A208719-001 | AB |
| A208719-002 | AB |
| A208719-003 | AB |
| A208719-004 | AB |
Observed Orange Book product history#
Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
| Captured | Edition | Application-product | Trade name | Strength | Dosage form / route | Product TE source text | RLD / RS | Approval date | Source SHA-256 |
|---|---|---|---|---|---|---|---|---|---|
| 2026-08-01 22:54:32 | 2026-06 | A208719-001 | DOXAZOSIN MESYLATE | EQ 1MG BASE | TABLET / ORAL | AB | 2017-07-07 | a50c72e98297… | |
| 2026-08-01 22:54:32 | 2026-06 | A208719-002 | DOXAZOSIN MESYLATE | EQ 2MG BASE | TABLET / ORAL | AB | 2017-07-07 | a50c72e98297… | |
| 2026-08-01 22:54:32 | 2026-06 | A208719-003 | DOXAZOSIN MESYLATE | EQ 4MG BASE | TABLET / ORAL | AB | 2017-07-07 | a50c72e98297… | |
| 2026-08-01 22:54:32 | 2026-06 | A208719-004 | DOXAZOSIN MESYLATE | EQ 8MG BASE | TABLET / ORAL | AB | 2017-07-07 | a50c72e98297… |
Observed Orange Book normalized TE history#
| Captured | Edition | Application-product | TE code | Order | Source SHA-256 |
|---|---|---|---|---|---|
| 2026-08-01 22:54:32 | 2026-06 | A208719-001 | AB | 1 | a50c72e98297… |
| 2026-08-01 22:54:32 | 2026-06 | A208719-002 | AB | 1 | a50c72e98297… |
| 2026-08-01 22:54:32 | 2026-06 | A208719-003 | AB | 1 | a50c72e98297… |
| 2026-08-01 22:54:32 | 2026-06 | A208719-004 | AB | 1 | a50c72e98297… |
openFDA label cross-check#
Cross-check layer: openFDA label JSON enriches search and identifies hydration gaps. The DailyMed Structured Product Label remains the canonical label presentation on FDA.report. Every label matching the complete exact-identifier union is deduplicated and paginated below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Doxazosin | DOXAZOSIN | REMEDYREPACK INC. | ec06f008-37a1-4757-a3ee-0b4720912bc4 | 2026-06-11 | Warnings, Adverse reactions | 208719 ANDA208719 |
| Doxazosin | DOXAZOSIN | NuCare Pharmaceuticals, Inc. | 30b709d6-c438-c721-e063-6294a90abd61 | 2025-03-19 | Warnings, Adverse reactions | 208719 ANDA208719 |
| Doxazosin | DOXAZOSIN | NuCare Pharmaceuticals,Inc. | 88efdfb0-710f-768a-e053-2995a90aede4 | 2024-12-17 | Warnings, Adverse reactions | 208719 ANDA208719 |
| Doxazosin | DOXAZOSIN | Zydus Lifesciences Limited | ac889877-133c-4448-af5a-d77b3cbfe878 | 2024-11-28 | 208719 ANDA208719 | |
| Doxazosin | DOXAZOSIN | A-S Medication Solutions | 46b01b1d-c48a-4c36-bf3c-bba98066166c | 2024-06-10 | Warnings, Adverse reactions | 208719 ANDA208719 |
| Doxazosin | DOXAZOSIN | Aphena Pharma Solutions - Tennessee, LLC | 187bc51b-7a3a-5910-e063-6294a90aa888 | 2024-05-15 | Warnings, Adverse reactions | 208719 ANDA208719 |
| Doxazosin | DOXAZOSIN | Bryant Ranch Prepack | 6fbb9ca2-e8ca-45c7-a178-b4c8dd7a9a1f | 2024-04-29 | Warnings, Adverse reactions | 208719 ANDA208719 |
| Doxazosin | DOXAZOSIN | Zydus Pharmaceuticals USA Inc. | e4758bf9-b9d4-4268-beb8-0d7e06890895 | 2023-09-16 | Warnings, Adverse reactions | 208719 ANDA208719 68382-783 |
Additional Listing Data#
- Finished product
- Yes
- Brand name base
- Doxazosin
- Listing expiration
- 2026-12-31
Active Ingredients#
| Ingredient | Strength |
|---|---|
| DOXAZOSIN MESYLATE | 1 mg/1 |
Harmonized UNII identifiers#
| Identifier | FDA.report destination |
|---|---|
| 86P6PQK0MU | Internal UNII lookup |
Harmonized RxCUI identifiers#
Harmonized SPL set identifiers#
| Identifier | FDA.report destination |
|---|---|
| e4758bf9-b9d4-4268-beb8-0d7e06890895 | Available on FDA.report |
DailyMed Product Concepts#
| Product concept | Relation | Version | Effective |
|---|---|---|---|
| 07a517fc-5845-3816-0f81-0a121804ec9e | Product name | 6 | 20250107 |
| 171dd63c-7eea-ede4-c010-4c25ba0a1087 | Product name | 1 | 20140508 |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 68382-783-01 | Doxazosin | 100 in 1 BOTTLE | TABLET | 100 | 4 | |
| 68382-783-06 | Doxazosin | 30 in 1 BOTTLE | TABLET | 30 | 4 | |
| 68382-783-10 | Doxazosin | 1000 in 1 BOTTLE | TABLET | 1000 | 4 | |
| 68382-783-30 | Doxazosin | 10 in 1 BLISTER PACK | TABLET | 10 | 4 | |
| 68382-783-77 | Doxazosin | 10 in 1 CARTON | TABLET | 10 | 4 |
DailyMed Billing Units#
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 68382-783-01 | EA - Each | 68382-783 | c206724c-df31-490b-9d3a-d9e02c83b03f | 1 | 2018-03-08 |
| 68382-783-10 | EA - Each | 68382-783 | c25b3680-a036-4c46-a5d5-c733f5c69987 | 1 | 2018-03-08 |
DailyMed Dashboard NDC Coverage#
DailyMed RxNorm Mappings#
| RxCUI | RxNorm string | TTY | DailyMed | SPL version |
|---|---|---|---|---|
| 197625 | doxazosin mesylate 1 MG Oral Tablet | PSN | e4758bf9-b9d4-4268-beb8-0d7e06890895 | 4 |
| 197626 | doxazosin mesylate 2 MG Oral Tablet | PSN | e4758bf9-b9d4-4268-beb8-0d7e06890895 | 4 |
| 197627 | doxazosin mesylate 4 MG Oral Tablet | PSN | e4758bf9-b9d4-4268-beb8-0d7e06890895 | 4 |
| 197628 | doxazosin mesylate 8 MG Oral Tablet | PSN | e4758bf9-b9d4-4268-beb8-0d7e06890895 | 4 |
| 197625 | doxazosin 1 MG Oral Tablet | SCD | e4758bf9-b9d4-4268-beb8-0d7e06890895 | 4 |
| 197626 | doxazosin 2 MG Oral Tablet | SCD | e4758bf9-b9d4-4268-beb8-0d7e06890895 | 4 |
| 197627 | doxazosin 4 MG Oral Tablet | SCD | e4758bf9-b9d4-4268-beb8-0d7e06890895 | 4 |
| 197628 | doxazosin 8 MG Oral Tablet | SCD | e4758bf9-b9d4-4268-beb8-0d7e06890895 | 4 |
| 197625 | doxazosin (as doxazosin mesylate) 1 MG Oral Tablet | SY | e4758bf9-b9d4-4268-beb8-0d7e06890895 | 4 |
| 197626 | doxazosin (as doxazosin mesylate) 2 MG Oral Tablet | SY | e4758bf9-b9d4-4268-beb8-0d7e06890895 | 4 |
| 197627 | doxazosin (as doxazosin mesylate) 4 MG Oral Tablet | SY | e4758bf9-b9d4-4268-beb8-0d7e06890895 | 4 |
| 197628 | doxazosin (as doxazosin mesylate) 8 MG Oral Tablet | SY | e4758bf9-b9d4-4268-beb8-0d7e06890895 | 4 |
| 197625 | doxazosin mesylate 1 MG Oral Tablet | PSN | ad7a234d-c1c2-44a1-830e-f97e202cbeab | 3 |
| 197625 | doxazosin 1 MG Oral Tablet | SCD | ad7a234d-c1c2-44a1-830e-f97e202cbeab | 3 |
| 197625 | doxazosin (as doxazosin mesylate) 1 MG Oral Tablet | SY | ad7a234d-c1c2-44a1-830e-f97e202cbeab | 3 |
Packages#
| Package NDC | 11-digit format | Description | Units | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|---|---|---|---|---|---|---|---|
| 68382-783-01 | 68382078301 | 100 TABLET in 1 BOTTLE (68382-783-01) | 100 tablet | 2017-08-31 | 0000-00-00 | No | No | Current |
| 68382-783-06 | 68382078306 | 30 TABLET in 1 BOTTLE (68382-783-06) | 30 tablet | 2017-08-31 | 0000-00-00 | No | No | Current |
| 68382-783-10 | 68382078310 | 1000 TABLET in 1 BOTTLE (68382-783-10) | 1000 tablet | 2017-08-31 | 0000-00-00 | No | No | Current |
| 68382-783-30 | 68382078330 | 10 in 1 BLISTER PACK | Historical | |||||
| 68382-783-77 | 68382078377 | 10 BLISTER PACK in 1 CARTON (68382-783-77) / 10 TABLET in 1 BLISTER PACK (68382-783-30) | 10 blister pack | 2017-08-31 | 0000-00-00 | No | No | Current |